Pharmacovigilance – News and Features

Roche Diagnostics have annouced that researchers have used the Genome Sequencer 20 technology to find the target and mechanism of action of a lead anti-TB agent.

Cogenics Provides a Broad Range of Pharmacogenomics and Molecular Services.

The scientific community will be gathering from 8 to 11 May 2006 for the 9th MipTec in Basel.

Gene-based drug targeting platform technology, has been shown to be effective in stopping tumour development.

Patent covers any therapeutic gene in combination with radiation and chemotherapy.

Both Companies have announced license agreement for the development of a humanized monoclonal antibody 'MNAC13'.

Research to concentrate on biomarkers for a pre-clinical drug efficacy study in the field of oncology.

This is thought to be a crucial step forward for researchers who are developing drugs to combat cancer and other diseases.

Biopharmaceutical Company selects Drug Model Explorer™ for model-based product profile visualization.

This collaboration leverages the growing field of computational biology to speed research and directly impact patients.